{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:16:52Z","timestamp":1762161412810},"reference-count":28,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2018,11,14]]},"DOI":"10.1167\/tvst.7.6.2","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T17:01:04Z","timestamp":1542214864000},"page":"2","source":"Crossref","is-referenced-by-count":1,"title":["Intravitreal Trimethoprim and Sulfamethoxazole Toxicity to the Retina of Albino Rabbits"],"prefix":"10.1167","volume":"7","author":[{"given":"Orit","family":"Mazza","sequence":"first","affiliation":[{"name":"Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology and the Rappaport Institute, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohar","family":"Habot-Wilner","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Shahar","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irit","family":"Mann","sequence":"additional","affiliation":[{"name":"Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology and the Rappaport Institute, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Loewenstein","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido","family":"Perlman","sequence":"additional","affiliation":[{"name":"Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology and the Rappaport Institute, Haifa, Israel"},{"name":"Division of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27","reference":[{"key":"i2164-2591-7-6-2-b01","doi-asserted-by":"crossref","unstructured":"Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol. 2003; 136: 973\u2013988.","DOI":"10.1016\/j.ajo.2003.09.040"},{"key":"i2164-2591-7-6-2-b02","doi-asserted-by":"crossref","unstructured":"Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009; 49: 878\u2013884.","DOI":"10.1086\/605433"},{"key":"i2164-2591-7-6-2-b03","doi-asserted-by":"crossref","unstructured":"Harrell M, Carvounis PE. Current treatment of toxoplasma retinochoroiditis: an evidence-based review. J Ophthalmol. 2014; 2014. doi:10.1155\/2014\/273506.","DOI":"10.1155\/2014\/273506"},{"key":"i2164-2591-7-6-2-b04","doi-asserted-by":"crossref","unstructured":"Wormser GP, Keusch GT, Heel R. Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. Drugs. 1982; 24: 459\u2013518.","DOI":"10.2165\/00003495-198224060-00002"},{"key":"i2164-2591-7-6-2-b05","doi-asserted-by":"crossref","unstructured":"Opremcak EM, Scales DK, Sharpe MR. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis. Ophthalmology. 1992; 99: 920\u2013925.","DOI":"10.1016\/S0161-6420(92)31873-1"},{"key":"i2164-2591-7-6-2-b06","doi-asserted-by":"crossref","unstructured":"Rothova A, Meenken C, Buitenhuis HJ, et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol. 1993; 115: 517\u2013523.","DOI":"10.1016\/S0002-9394(14)74456-3"},{"key":"i2164-2591-7-6-2-b07","doi-asserted-by":"crossref","unstructured":"Soheilian M, Sadoughi MM, Ghajarnia M, et al. Prospective randomized trial of trimethoprim\/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology. 2005; 112: 1876\u20131884.","DOI":"10.1016\/j.ophtha.2005.05.025"},{"key":"i2164-2591-7-6-2-b08","doi-asserted-by":"crossref","unstructured":"Yazici A, Ozdal P\u00c7, Taskintuna I, Kavuncu S, Koklu G. Trimethoprim\/sulfamethoxazole and azithromycin combination therapy for ocular toxoplasmosis. Ocul Immunol Inflamm. 2009; 17: 289\u2013291.","DOI":"10.1080\/09273940802687846"},{"key":"i2164-2591-7-6-2-b09","doi-asserted-by":"crossref","unstructured":"Lashay A, Mirshahi A, Parandin N, et al. A prospective randomized trial of azithromycin versus trimethoprim\/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis. J Curr Ophthalmol. 2017; 29: 120\u2013125.","DOI":"10.1016\/j.joco.2016.10.002"},{"key":"i2164-2591-7-6-2-b10","unstructured":"Lee YF, Chen SJ, Chung YM, Liu JH, Wong WW. Diffuse toxoplasmic retinochoroiditis as the initial manifestation of acquired immunodeficiency syndrome. J Formos Med Assoc. 2000; 99: 219\u2013223."},{"key":"i2164-2591-7-6-2-b11","doi-asserted-by":"crossref","unstructured":"Silveira C, Belfort R, Muccioli C, et al. The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002; 134: 41\u201346.","DOI":"10.1016\/S0002-9394(02)01527-1"},{"key":"i2164-2591-7-6-2-b12","doi-asserted-by":"crossref","unstructured":"Felix JPF, Lira RPC, Zacchia RS, et al. Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of toxoplasma gondii retinochoroiditis: randomized controlled clinical trial. Am J Ophthalmol. 2014; 157: 762\u2013766.","DOI":"10.1016\/j.ajo.2013.12.022"},{"key":"i2164-2591-7-6-2-b13","doi-asserted-by":"crossref","unstructured":"Fernandes Felix JP, Cavalcanti Lira RP, Cosimo AB, et al. Trimethoprim-Sulfamethoxazole versus placebo in reducing the risk of toxoplasmic retinochoroiditis recurrences: a three-year follow-up. Am J Ophthalmol. 2016; 170: 176\u2013182.","DOI":"10.1016\/j.ajo.2016.08.003"},{"key":"i2164-2591-7-6-2-b14","doi-asserted-by":"crossref","unstructured":"Choudhury H, Jindal A, Pathengay A, et al. The role of intravitreal trimethoprim\/sulfamethoxazole in the treatment of toxoplasma retinochoroiditis. Ophthalmic Surg Lasers Imaging Retina. 2015; 46: 137\u2013140.","DOI":"10.3928\/23258160-20150101-27"},{"key":"i2164-2591-7-6-2-b15","doi-asserted-by":"crossref","unstructured":"Souza CE, Nascimento H, Lima A, Muccioli C, Belfort R. Intravitreal injection of sulfamethoxazole and trimethoprim associated with dexamethasone as an alternative therapy for ocular toxoplasmosis [published online ahead of print April 27, 2017]. Ocul Immunol Inflamm. doi: 10.1080\/09273948.2017.1307420.","DOI":"10.1080\/09273948.2017.1307420"},{"key":"i2164-2591-7-6-2-b16","doi-asserted-by":"crossref","unstructured":"Fiscella R, Peyman GA, Kimura A, Small G. Intravitreal toxicity of cotrimoxazole. Ophthalmic Surg. 1988; 19: 44\u201346.","DOI":"10.3928\/1542-8877-19880101-12"},{"key":"i2164-2591-7-6-2-b17","doi-asserted-by":"crossref","unstructured":"Habot-Wilner Z, Mazza O, Shahar J, et al. Saftey of intravitreal clindamycin in albino rabbit eyes. Doc Ophthalmol, 2017; 135: 133\u2013134.","DOI":"10.1007\/s10633-017-9599-5"},{"key":"i2164-2591-7-6-2-b18","unstructured":"Loewenstein A, Zemel E, Lazar M, Perlman I. Drug-induced retinal toxicity in albino rabbits: the effects of imipenem and aztreonam. Investig Ophthalmol Vis Sci. 1993; 34: 3466\u20133476."},{"key":"i2164-2591-7-6-2-b19","doi-asserted-by":"crossref","unstructured":"McCulloch DL, Marmor MF, Brigell MG, et al. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015; 130: 1\u201312.","DOI":"10.1007\/s10633-014-9473-7"},{"key":"i2164-2591-7-6-2-b20","doi-asserted-by":"crossref","unstructured":"Bresnick GH, Palta M. Oscillatory potential amplitudes. Relation to severity of diabetic retinopathy. Arch Ophthalmol (Chicago, Ill 1960). 1987; 105: 929\u2013933.","DOI":"10.1001\/archopht.1987.01060070065030"},{"key":"i2164-2591-7-6-2-b21","doi-asserted-by":"crossref","unstructured":"Fulton AB, Hansen RM. Scotopic stimulus\/response relations of the b-wave of the electroretinogram. Doc Ophthalmol. 1988; 68: 293\u2013304.","DOI":"10.1007\/BF00156435"},{"key":"i2164-2591-7-6-2-b22","doi-asserted-by":"crossref","unstructured":"Perlman I. Testing retinal toxicity of drugs in animal models using electrophysiological and morphological techniques. Doc Ophthalmol. 2009; 118: 3\u201328.","DOI":"10.1007\/s10633-008-9153-6"},{"key":"i2164-2591-7-6-2-b23","doi-asserted-by":"crossref","unstructured":"Habot-Wilner Z, Shahar J, Zemel E, Loewenstein A, Perlman I. Retinal toxicity of intravitreal retuximab in albino rabbits. Retina. 2013; 33: 649\u2013656.","DOI":"10.1097\/IAE.0b013e318263d14f"},{"key":"i2164-2591-7-6-2-b24","doi-asserted-by":"crossref","unstructured":"Okada M, Matsumura M, Ogino N, Honda Y. M\u00fcller cells in detached human retina express glial fibrillary acidic protein and vimentin. Graefes Arch Clin Exp Ophthalmol. 1990; 228: 467\u2013474.","DOI":"10.1007\/BF00927264"},{"key":"i2164-2591-7-6-2-b25","doi-asserted-by":"crossref","unstructured":"Li Q, Zemel E, Miller B, Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res. 2002; 74: 615\u2013625.","DOI":"10.1006\/exer.2002.1170"},{"key":"i2164-2591-7-6-2-b26","doi-asserted-by":"crossref","unstructured":"Sarthy V. Focus on molecules: glial fibrillary acidic protein (GFAP). Exp Eye Res. 2007; 84: 381\u2013382.","DOI":"10.1016\/j.exer.2005.12.014"},{"key":"i2164-2591-7-6-2-b27","doi-asserted-by":"crossref","unstructured":"Wachtmeister L. Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res. 1998; 17: 485\u2013521.","DOI":"10.1016\/S1350-9462(98)00006-8"},{"key":"i2164-2591-7-6-2-b28","doi-asserted-by":"crossref","unstructured":"Perlman I. Relationship between the amplitudes of the b wave and the a wave as a useful index for evaluating the electroretinogram. Br J Ophthalmol. 1983; 67: 443\u2013448.","DOI":"10.1136\/bjo.67.7.443"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?articleid=2714584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:58:05Z","timestamp":1662425885000},"score":1,"resource":{"primary":{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.7.6.2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.7.6.2","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11,14]]}}}